the Web site devoted to the study of the glucagon-like peptides

This Web site is maintained by Dr. Daniel J. Drucker, Mount Sinai Hospital Lunenfeld-Tanenbaum Research Institute University of Toronto

GLP-1 in response to oral glucose, lessons from the ADDITION-PRO study GLP-1 synthesis and secretion, and degradation

Glucagon Cell Adenomatosis (GCA) in the human pancreas, with and without GCGR mutations Glucagon receptor

Native GLP-1 protects the ischemic human ventricle again, independent of glucose utilization GLP-1 and the cardiovascular system

Save the dates-Lunenfeld Tanenbaum Symposium Molecular concepts and translational innovation in metabolism May 26 2015

Incretin 2015-The 45th Anniversary of GIP and more: Vancouver July 29-August 1 2015


For updates to, Follow us on Twitter DanielJDrucker